美国Cephalon Inc. www.cephalon.com
美国生物制药商Cephalon Inc.(CEPH) 如今的Cephalon 公司已经是一个拥有3000 名雇员和年销售额近20 亿美元的跨国生物技术公司。
致力于为中枢神经系统，炎症性疾病，疼痛，肿瘤治疗领域发现、开发产品并使之商业化。该公司作为以生物技术开发为主成立于1987年，已经成长为世界十大生物制药公司之一，以一流的产品，一个深化和多样化的管道。
2011年以色列Teva制药出价68亿美元收购美国Cephalon

 

At Cephalon, we never lose sight of why we’re in business: to improve health and enhance the quality of the lives of patients through smart application of science.

Founded in 1987 as a biotech start-up, we have grown into one of the world’s top ten biopharmaceutical companies, with an impressive roster of first-in-class products, a deep and diverse pipeline, and annual revenues of $1.94 billion. And even though we’ve grown to nearly 3,000 employees in locations around the globe, we’ve never lost the agility and nimbleness of a start-up.

Our portfolio of innovative treatments for central nervous system disorders, pain, and cancer include eight proprietary products in the United States, along with more than 30 products internationally. Our research pipeline is focused on developing new compounds and new indications for existing products, while our business collaborations capitalize on new products and smart drug delivery technologies.

The single greatest measure of our success will always be the countless people who benefit from our medications every day. They are our true legacy and why we do what we do.